Fact Sheet

Etubics initiated pre-clinical studies of its products in 2006 to develop and commercially exploit this technology for new prophylactic and therapeutic vaccines.
Corporate headquarters in Seattle, Wash.
9 employees
Exclusive technology licensed from the University of Michigan
Phase I/II human clinical trials for colon cancer vaccine began in Summer 2010.